Cite
HARVARD Citation
Polistena, B. et al. (2019). The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global & regional health technology assessment. p. . [Online].